Management of end-stage kidney failure: A challenge for the countries of sub-Saharan Africa: Example of mineral and bone disorders in Burkina Faso;Prise en charge de l'insuffisance rénale terminale: Un challenge pour les pays de l'Afrique subsaharienne: Exemple des désordres minéralo-osseux au Burkina Faso

Medecine et Sante Tropicales

Volumn 23, Issue 2, 2013, Pages 193-196

  Coulibaly, G ^a   Kabore G E ^a   Diallo, O ^a   Ouedraogo D D ^a   Fessi, H ^b   Ronco, P ^b   Zabsonre P ^a   Lengani, A ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE YALGADO OUÉDRAOGO   (Burkina Faso)

^b HÔPITAL TENON   (France)

Author keywords

Burkina Faso; Chronic kidney disease; Mineral bone disorders

Indexed keywords

MINERAL;

ADOLESCENT; ADULT; ARTICLE; BONE DISEASE; BURKINA FASO; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; METABOLIC DISORDER; METABOLISM; MIDDLE AGED; MINERAL-BONE DISORDERS; RENAL REPLACEMENT THERAPY; YOUNG ADULT;

BURKINA FASO; CHRONIC KIDNEY DISEASE; MINERAL-BONE DISORDERS;

ADOLESCENT; ADULT; BONE DISEASES; BURKINA FASO; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC DISEASES; MIDDLE AGED; MINERALS; RENAL DIALYSIS; YOUNG ADULT;

EID: 84887853085     PISSN: 22613684     EISSN: 22612211     Source Type: Journal    
DOI: 10.1684/mst.2013.0178     Document Type: Article

References (16)

1. Arogundade F, Barsoum R. Chronic kidney disease prevention in Sub-Saharan Africa: A call for govermental, nongovermental, and community support. Am J Kidney Dis 2008; 51: 515-23.
2. Naicker S. Challenges for nephrology practice in sub-saharan Africa. Nephrol Dial Transplant 2010; 25: 649-50.
3. Tentori F, Hunt WC, Rohrscheib M, et al. Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization? J Am Soc Nephrol 2007; 18: 2377-84.
4. Kidney Disease: Improving Global Outcomes (KDIGO). About us. Available on: www.kdigo.org/about_us.php.
5. Kidney Disease: Improving Global Outcomes work group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009;; S1-30.
6. United States Renal Data System. USRDS 2004 annual data report: Atlas of End stage renal disease in the United States. Available on: www.usrds.org/ atlas04.aspx.
7. Young E, Albert J, Sataya-Thum S, Goodkin D, Pisoni R, Akiba T. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005; 67: 1179-87.
8. Pelletier S, Roth H, Bouchet J, Drueke T, Hannedouche T, London G. Evolution de la prise en charge de la maladie osseuse et minérale des patients hémodialysés en France entre juin 2005 et juin 2008. Nephrol Ther 2010; 6: 11-20.
9. Benamar L, Rhou H, Guerraoui M, Bakkal B, Benjelloun H, Laouad I. Calcifications cardiovasculaires chez l'hémodialysé chronique. Prévalence et facteurs de risque. Néphrologie 2003; 24: 143-7.
10. Amali K, Benjelloun M, Tarrass F, Tarik A, Medkouri G, Zamd M. Le métabolisme phosphocalcique et nouvelles recommandations KDOQI: évaluation des pratiques d'un centre hospitalier. Abstract AD 013. Nephrol Ther 2006; 2: 256.
11. Afifi A, El-Sayed H, El-Setouhi M, Ahmed H, Khalifa N. Hyperphosphatemia among end-stage renal disease patients in developing countries: a forgotten issues? Hemodial Int 2005; 9: 409-15.
12. Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European hemodialysis population. Nephrol Dial Transplant 2011; 26: 1948-55.
13. Jean G, Souberbielle J-C, Lorriaux C, et al. Les formes cliniques et biologiques de l'hyperparathyroïdie secondaire en dialyse. Nephrol Ther 2012; 8: 35-40.
14. Joly D, Drueke T, Alberti C, et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a crosssectional study. Am J Kidney Dis 2008; 51: 987-95.
15. Shantouf R, Kovesdy C, Kim Y, Ahmadi N, Luna A, Luna C. Association of Serum Alkaline Phosphatase with Coronary Artery Calcification in Maintenance Hemodialysis Patients. Clin J AmSoc Nephrol 2009; 4: 1106-14.
16. Blayney M, Pisoni R, Bragg-Gresham J, Bommer J, Piera L, Saito A. High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int 2008; 74: 655-63.